Associations of 25-hydroxyvitamin D with Markers of Inflammation, Insulin Resistance and Obesity in Black and White Community-dwelling Adults
Overview
Authors
Affiliations
Aims: Vitamin D is a fat-soluble vitamin classically known for its role in calcium absorption and bone health. Growing evidence indicates that vitamin D deficiency may be associated with inflammation, insulin resistance, and obesity. However, prior studies examining the association of vitamin D with metabolic risk factors had relatively low representation of individuals of black race, limiting their ability to characterize associations of vitamin D and parameters of metabolic health in black vs. white individuals.
Methods: We examined associations of 25-hydroxyvitamin D (25(OH)D) concentrations with markers of inflammation (interleukin [IL]-6, IL-10, high sensitivity C-reactive protein [hsCRP]), insulin sensitivity (adiponectin, resistin, HOMA-IR), and obesity (body mass index [BMI], waist circumference) in 1,042 participants from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study, a large national cohort of black and white adults 45 years or older.
Results: In unadjusted analyses, lower 25(OH)D concentrations were associated with higher IL-6 and hsCRP concentrations; lower adiponectin concentrations; higher HOMA-IR; and higher BMI and waist circumference (<0.05 for all). After adjustment for sociodemographic, clinical, lifestyle, and laboratory variables, lower 25(OH) D concentrations remained associated with lower adiponectin concentrations, higher IL-6 concentrations, higher HOMA-IR, and higher BMI and waist circumference ( <0.05 for all). The magnitude of these associations did not differ by race (>0.1).
Conclusions: Lower 25(OH)D concentrations are associated with disturbances in metabolic health in both blacks and whites. Whether correcting vitamin D deficiency could offer a beneficial therapy for additional disease prevention requires further study.
Update on Biomarkers of Chronic Inflammatory Processes Underlying Diabetic Neuropathy.
Stoian A, Muntean C, Baba D, Manea A, Denes L, Simon-Szabo Z Int J Mol Sci. 2024; 25(19).
PMID: 39408723 PMC: 11476795. DOI: 10.3390/ijms251910395.
Dong H, Wang F, Gao L, Xu X, Ni Y BMJ Open. 2024; 14(9):e083227.
PMID: 39242162 PMC: 11381719. DOI: 10.1136/bmjopen-2023-083227.
Pediatric primary cutaneous anaplastic large-cell lymphoma with associated hypovitaminosis D.
Tung-Hahn E, Mogilevskiy V, Black E, Morgan M, Tung R Arch Dermatol Res. 2023; 316(1):50.
PMID: 38108932 DOI: 10.1007/s00403-023-02790-4.
Hofman-Hutna J, Hutny M, Matusik E, Olszanecka-Glinianowicz M, Matusik P Metabolites. 2023; 13(8).
PMID: 37623858 PMC: 10456245. DOI: 10.3390/metabo13080914.
Dietary inflammatory index is associated with Vitamin D in CKD patients.
Wu W, Li X, Di J, Zhou H, Niu H, Yang M Int Urol Nephrol. 2023; 56(1):335-344.
PMID: 37378851 PMC: 10776691. DOI: 10.1007/s11255-023-03679-x.